|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:EPC2-MYH11 (FusionGDB2 ID:HG26122TG4629) |
Fusion Gene Summary for EPC2-MYH11 |
Fusion gene summary |
Fusion gene information | Fusion gene name: EPC2-MYH11 | Fusion gene ID: hg26122tg4629 | Hgene | Tgene | Gene symbol | EPC2 | MYH11 | Gene ID | 26122 | 4629 |
Gene name | enhancer of polycomb homolog 2 | myosin heavy chain 11 | |
Synonyms | EPC-LIKE | AAT4|FAA4|SMHC|SMMHC | |
Cytomap | ('EPC2')('MYH11') 2q23.1 | 16p13.11 | |
Type of gene | protein-coding | protein-coding | |
Description | enhancer of polycomb homolog 2 | myosin-11epididymis secretory sperm binding proteinmyosin heavy chain, smooth muscle isoformmyosin, heavy chain 11, smooth musclemyosin, heavy polypeptide 11, smooth muscle | |
Modification date | 20200313 | 20200322 | |
UniProtAcc | Q52LR7 | P35749 | |
Ensembl transtripts involved in fusion gene | ENST00000258484, ENST00000409654, | ||
Fusion gene scores | * DoF score | 12 X 11 X 3=396 | 44 X 55 X 10=24200 |
# samples | 12 | 62 | |
** MAII score | log2(12/396*10)=-1.72246602447109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(62/24200*10)=-5.28659502177508 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: EPC2 [Title/Abstract] AND MYH11 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | EPC2(149526741)-MYH11(15818065), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | EPC2-MYH11 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EPC2-MYH11 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EPC2-MYH11 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. EPC2-MYH11 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across EPC2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across MYH11 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | BE837002 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
Top |
Fusion Gene ORF analysis for EPC2-MYH11 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000258484 | ENST00000573908 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
In-frame | ENST00000258484 | ENST00000300036 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
In-frame | ENST00000258484 | ENST00000396324 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
In-frame | ENST00000258484 | ENST00000452625 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
In-frame | ENST00000258484 | ENST00000576790 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
intron-3CDS | ENST00000409654 | ENST00000300036 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
intron-3CDS | ENST00000409654 | ENST00000396324 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
intron-3CDS | ENST00000409654 | ENST00000452625 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
intron-3CDS | ENST00000409654 | ENST00000576790 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
intron-intron | ENST00000409654 | ENST00000573908 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000258484 | EPC2 | chr2 | 149526741 | - | ENST00000396324 | MYH11 | chr16 | 15818065 | - | 3663 | 1242 | 34 | 1374 | 446 |
ENST00000258484 | EPC2 | chr2 | 149526741 | - | ENST00000452625 | MYH11 | chr16 | 15818065 | - | 3702 | 1242 | 34 | 1374 | 446 |
ENST00000258484 | EPC2 | chr2 | 149526741 | - | ENST00000576790 | MYH11 | chr16 | 15818065 | - | 3087 | 1242 | 34 | 1374 | 446 |
ENST00000258484 | EPC2 | chr2 | 149526741 | - | ENST00000300036 | MYH11 | chr16 | 15818065 | - | 2844 | 1242 | 34 | 1374 | 446 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000258484 | ENST00000396324 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - | 0.009926841 | 0.9900732 |
ENST00000258484 | ENST00000452625 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - | 0.010136104 | 0.98986393 |
ENST00000258484 | ENST00000576790 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - | 0.0113003 | 0.98869973 |
ENST00000258484 | ENST00000300036 | EPC2 | chr2 | 149526741 | - | MYH11 | chr16 | 15818065 | - | 0.008971636 | 0.99102837 |
Top |
Fusion Genomic Features for EPC2-MYH11 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for EPC2-MYH11 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:149526741/chr16:15818065) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
EPC2 | MYH11 |
FUNCTION: May play a role in transcription or DNA repair. {ECO:0000250}. | FUNCTION: Muscle contraction. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000300036 | 0 | 41 | 844_1934 | 0 | 1973.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000396324 | 0 | 42 | 844_1934 | 0 | 1980.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000452625 | 0 | 43 | 844_1934 | 0 | 2132.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000576790 | 0 | 42 | 844_1934 | 0 | 1912.6666666666667 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000300036 | 0 | 41 | 31_81 | 0 | 1973.0 | Domain | Myosin N-terminal SH3-like | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000300036 | 0 | 41 | 786_815 | 0 | 1973.0 | Domain | IQ | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000300036 | 0 | 41 | 85_783 | 0 | 1973.0 | Domain | Myosin motor | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000396324 | 0 | 42 | 31_81 | 0 | 1980.0 | Domain | Myosin N-terminal SH3-like | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000396324 | 0 | 42 | 786_815 | 0 | 1980.0 | Domain | IQ | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000396324 | 0 | 42 | 85_783 | 0 | 1980.0 | Domain | Myosin motor | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000452625 | 0 | 43 | 31_81 | 0 | 2132.0 | Domain | Myosin N-terminal SH3-like | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000452625 | 0 | 43 | 786_815 | 0 | 2132.0 | Domain | IQ | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000452625 | 0 | 43 | 85_783 | 0 | 2132.0 | Domain | Myosin motor | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000576790 | 0 | 42 | 31_81 | 0 | 1912.6666666666667 | Domain | Myosin N-terminal SH3-like | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000576790 | 0 | 42 | 786_815 | 0 | 1912.6666666666667 | Domain | IQ | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000576790 | 0 | 42 | 85_783 | 0 | 1912.6666666666667 | Domain | Myosin motor | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000300036 | 0 | 41 | 178_185 | 0 | 1973.0 | Nucleotide binding | ATP | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000396324 | 0 | 42 | 178_185 | 0 | 1980.0 | Nucleotide binding | ATP | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000452625 | 0 | 43 | 178_185 | 0 | 2132.0 | Nucleotide binding | ATP | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000576790 | 0 | 42 | 178_185 | 0 | 1912.6666666666667 | Nucleotide binding | ATP | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000300036 | 0 | 41 | 1935_1972 | 0 | 1973.0 | Region | Note=C-terminal | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000300036 | 0 | 41 | 661_683 | 0 | 1973.0 | Region | Actin-binding | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000300036 | 0 | 41 | 762_776 | 0 | 1973.0 | Region | Actin-binding | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000396324 | 0 | 42 | 1935_1972 | 0 | 1980.0 | Region | Note=C-terminal | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000396324 | 0 | 42 | 661_683 | 0 | 1980.0 | Region | Actin-binding | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000396324 | 0 | 42 | 762_776 | 0 | 1980.0 | Region | Actin-binding | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000452625 | 0 | 43 | 1935_1972 | 0 | 2132.0 | Region | Note=C-terminal | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000452625 | 0 | 43 | 661_683 | 0 | 2132.0 | Region | Actin-binding | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000452625 | 0 | 43 | 762_776 | 0 | 2132.0 | Region | Actin-binding | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000576790 | 0 | 42 | 1935_1972 | 0 | 1912.6666666666667 | Region | Note=C-terminal | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000576790 | 0 | 42 | 661_683 | 0 | 1912.6666666666667 | Region | Actin-binding | |
Tgene | MYH11 | chr2:149526741 | chr16:15818065 | ENST00000576790 | 0 | 42 | 762_776 | 0 | 1912.6666666666667 | Region | Actin-binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EPC2 | chr2:149526741 | chr16:15818065 | ENST00000258484 | - | 1 | 14 | 483_488 | 0 | 808.0 | Compositional bias | Note=Poly-Ser |
Hgene | EPC2 | chr2:149526741 | chr16:15818065 | ENST00000258484 | - | 1 | 14 | 582_619 | 0 | 808.0 | Compositional bias | Note=Gln-rich |
Top |
Fusion Gene Sequence for EPC2-MYH11 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>26909_26909_1_EPC2-MYH11_EPC2_chr2_149526741_ENST00000258484_MYH11_chr16_15818065_ENST00000300036_length(transcript)=2844nt_BP=1242nt GCCGCCCGGGCTGTTCCTGTAAGGCGGGGAGACAATGAGTAAACTCTCCTTCCGAGCGCGGGCGCTGGACGCCGCCAAGCCGCTGCCTAT CTACCGCGGCAAGGACATGCCTGATCTCAACGACTGCGTCTCCATCAACCGGGCCGTGCCCCAGATGCCCACCGGGATGGAGAAGGAGGA GGAATCGGAACATCATTTACAGCGAGCAATTTCAGCACAGCAAGTGTTTAGAGAAAAAAAAGAGAGTATGGTCATTCCTGTTCCTGAGGC AGAGAGCAACGTCAACTATTACAATCGCTTGTACAAAGGAGAGTTTAAACAGCCAAAACAGTTCATTCATATTCAGCCTTTTAATCTAGA CAACGAGCAACCAGATTATGATATGGATTCAGAAGATGAGACTTTATTAAATAGACTTAACAGAAAGATGGAAATTAAGCCTTTGCAATT TGAAATTATGATTGACAGACTTGAAAAAGCCAGTTCTAATCAGCTTGTAACACTTCAAGAAGCAAAACTGCTGCTAAACGAAGATGATTA CCTTATTAAAGCTGTATATGACTACTGGGTGAGAAAACGTAAAAACTGCAGGGGGCCATCCCTCATTCCTCAGATAAAACAAGAGAAAAG AGATGGCTCTACCAACAATGACCCTTATGTTGCCTTTCGGAGAAGAACAGAGAAAATGCAAACTCGAAAGAATCGTAAGAATGATGAAGC CTCTTATGAAAAGATGTTGAAACTGAGACGAGAATTTAGTAGAGCCATAACAATTTTGGAAATGATTAAGAGAAGAGAGAAAACAAAACG AGAATTATTGCACTTAACCTTAGAAGTTGTGGAGAAAAGATACCATTTGGGAGACTATGGTGGTGAAATCCTTAATGAAGTAAAAATCAG TAGATCAGAAAAAGAGTTATATGCCACTCCAGCAACTCTTCATAATGGAAATCATCACAAAGTTCAAGAATGTAAAACTAAGCACCCTCA TCATTTGTCTTTGAAAGAAGAGGCTTCTGATGTGGTTCGTCAAAAGAAGAAGTACCCAAAGAAGCCTAAAGCAGAGGCTTTGATAACATC TCAGCAACCCACTCCTGAGACATTGCCTGTGATCAATAAGAGTGACATTAAGCAATATGATTTTCACAGCTCAGATGAAGATGAATTTCC ACAGCGGAAGAAGAAAATGATCCTGATGGTCCCTGTGCTTTCAGAAGGCGGGCAGGATGCCAGTATTATGCTGCGAGGAAACGAGACCTC TTTCGTTCCTTCTAGAAGGTCTGGAGGACGTAGAGTTATTGAAAATGCAGATGGTTCTGAGGAGGAAACGGACACTCGAGACGCAGACTT CAATGGAACCAAGGCCAGTGAATAAGCAGAGAAAGGCAATGCCAGGGTCAAGCAGCTCAAGAGGCAGCTGGAGGAGGCAGAGGAGGAGTC CCAGCGCATCAACGCCAACCGCAGGAAGCTGCAGCGGGAGCTGGATGAGGCCACGGAGAGCAACGAGGCCATGGGCCGCGAGGTGAACGC ACTCAAGAGCAAGCTCAGAGAGAAACAGGCGGCCACCAAGTCGCTGAAGCAGAAAGACAAGAAGCTGAAGGAAATCTTGCTGCAGGTGGA GGACGAGCGCAAGATGGCCGAGCAGTACAAGGAGCAGGCCGAGCAGCTCAGCAACGAGCTGGCCACAGAGCGCAGCACGGCCCAGAAGAA TGAGAGTGCCCGGCAGCAGCTCGAGCGGCAGAACAAGGAGCTCCGGAGCAAGCTCCACGAGATGGAGGGGGCCGTCAAGTCCAAGTTCAA GTCCACCATCGCGGCGCTGGAGGCCAAGATTGCACAGCTGGAGGAGCAGGTCGAGCAGGAGGCCAGGAACGCACTCCAGGACGAGAAGCG CCGCCTGGAGGCCCGGATCGCCCAGCTGGAGGAGGAGCTGGAGGAGGAGCAGGGCAACATGGAGGCCATGAGCGACCGGGTCCGCAAAGC CACACAGCAGGACCTCGCCGCCGCTGAGAGGGCTCGCAAACAAGCGGACCTCGAGAAGGAGGAACTGGCAGAGGAGCTGGCCAGTAGCCT GTCGGGAAGGCTCAGATGAAGGACTTTCAAAGAGAGCTGGAAGATGCCCGTGCCTCCAGAGATGAGATCTTTGCCACAGCCAAAGAGAAT GAGAAGAAAGCCAAGAGCTTGGAAGCAGACCTCATGCAGCTACAAGAGCTTCACGAGTATGAGACGGAACTGGAAGACGAGCGAAAGCAA CGTGCCCTGGCAGCTGCAGCAAAGAAGAAGCTGGAAGGGGACCTGAAAGACCTGGAGCTTCAGGCCGACTCTGCCATCAAGGGGAGGGAG GAAGCCATCAAGCAGCTACGCAAACTGCAGGTCCATGAGCTGGAGAAGTCCAAGCGGGCCCTGGAGACCCAGATGGAGGAGATGAAGACG CAGCTGGAAGAGCTGGAGGACGAGCTGCAAGCCACGGAGGACGCCAAACTGCGGCTGGAAGTCAACATGCAGGCGCTCAAGGGCCAGTTC GAAAGGGATCTCCAAGCCCGGGACGAGCAGAATGAGGAGAAGAGGAGGCAACTGCAGAGACAGTTGTTAGCCGAGGAGAAAAACATCTCT TCCAAATACGCGGATGAGAGGGACAGAGCTGAGGCAGAAGCCAGGGAGAAGGAAACCAAGGCCCTGTCCCTGGCTCGGGCCCTTGAAGAG GCCTTGGAAGCCAAAGAGGAACTCGAGCGGACCAACAAAATGCTCAAAGCCGAAATGGAAGACCTGGTCAGCTCCAAGGATGACGTGGGC >26909_26909_1_EPC2-MYH11_EPC2_chr2_149526741_ENST00000258484_MYH11_chr16_15818065_ENST00000300036_length(amino acids)=446AA_BP= MSKLSFRARALDAAKPLPIYRGKDMPDLNDCVSINRAVPQMPTGMEKEEESEHHLQRAISAQQVFREKKESMVIPVPEAESNVNYYNRLY KGEFKQPKQFIHIQPFNLDNEQPDYDMDSEDETLLNRLNRKMEIKPLQFEIMIDRLEKASSNQLVTLQEAKLLLNEDDYLIKAVYDYWVR KRKNCRGPSLIPQIKQEKRDGSTNNDPYVAFRRRTEKMQTRKNRKNDEASYEKMLKLRREFSRAITILEMIKRREKTKRELLHLTLEVVE KRYHLGDYGGEILNEVKISRSEKELYATPATLHNGNHHKVQECKTKHPHHLSLKEEASDVVRQKKKYPKKPKAEALITSQQPTPETLPVI -------------------------------------------------------------- >26909_26909_2_EPC2-MYH11_EPC2_chr2_149526741_ENST00000258484_MYH11_chr16_15818065_ENST00000396324_length(transcript)=3663nt_BP=1242nt GCCGCCCGGGCTGTTCCTGTAAGGCGGGGAGACAATGAGTAAACTCTCCTTCCGAGCGCGGGCGCTGGACGCCGCCAAGCCGCTGCCTAT CTACCGCGGCAAGGACATGCCTGATCTCAACGACTGCGTCTCCATCAACCGGGCCGTGCCCCAGATGCCCACCGGGATGGAGAAGGAGGA GGAATCGGAACATCATTTACAGCGAGCAATTTCAGCACAGCAAGTGTTTAGAGAAAAAAAAGAGAGTATGGTCATTCCTGTTCCTGAGGC AGAGAGCAACGTCAACTATTACAATCGCTTGTACAAAGGAGAGTTTAAACAGCCAAAACAGTTCATTCATATTCAGCCTTTTAATCTAGA CAACGAGCAACCAGATTATGATATGGATTCAGAAGATGAGACTTTATTAAATAGACTTAACAGAAAGATGGAAATTAAGCCTTTGCAATT TGAAATTATGATTGACAGACTTGAAAAAGCCAGTTCTAATCAGCTTGTAACACTTCAAGAAGCAAAACTGCTGCTAAACGAAGATGATTA CCTTATTAAAGCTGTATATGACTACTGGGTGAGAAAACGTAAAAACTGCAGGGGGCCATCCCTCATTCCTCAGATAAAACAAGAGAAAAG AGATGGCTCTACCAACAATGACCCTTATGTTGCCTTTCGGAGAAGAACAGAGAAAATGCAAACTCGAAAGAATCGTAAGAATGATGAAGC CTCTTATGAAAAGATGTTGAAACTGAGACGAGAATTTAGTAGAGCCATAACAATTTTGGAAATGATTAAGAGAAGAGAGAAAACAAAACG AGAATTATTGCACTTAACCTTAGAAGTTGTGGAGAAAAGATACCATTTGGGAGACTATGGTGGTGAAATCCTTAATGAAGTAAAAATCAG TAGATCAGAAAAAGAGTTATATGCCACTCCAGCAACTCTTCATAATGGAAATCATCACAAAGTTCAAGAATGTAAAACTAAGCACCCTCA TCATTTGTCTTTGAAAGAAGAGGCTTCTGATGTGGTTCGTCAAAAGAAGAAGTACCCAAAGAAGCCTAAAGCAGAGGCTTTGATAACATC TCAGCAACCCACTCCTGAGACATTGCCTGTGATCAATAAGAGTGACATTAAGCAATATGATTTTCACAGCTCAGATGAAGATGAATTTCC ACAGCGGAAGAAGAAAATGATCCTGATGGTCCCTGTGCTTTCAGAAGGCGGGCAGGATGCCAGTATTATGCTGCGAGGAAACGAGACCTC TTTCGTTCCTTCTAGAAGGTCTGGAGGACGTAGAGTTATTGAAAATGCAGATGGTTCTGAGGAGGAAACGGACACTCGAGACGCAGACTT CAATGGAACCAAGGCCAGTGAATAAGCAACTTTCTACAGTTTTGCACCACGGCAAGAAAACCAAAAACCAAAACAAACAAACAAAAAAAA CCCAACAACAACCCAGAACAAAGCAAAACCCAGCAGACTGTACTTAGCATTGTCTAAATCCATTCTCAAATTCCAAATATCACAGACACC CCTCACACAAGGAATATAAAAACCACCACCCTCCAGCCTGGGCAACGTAGTAAAACCTCATCTATACAAGAATTTAAAAATAAGCTGGGC GTGGTGGTACACACCTGTGGTCCCAGCTACTAGGGAGGCTGAGCCAGGAAGAACGCTCCAGCCCAGGACTTCGAGGCTGCAATGAGCTAT AATTGCATCATTGCACTCCAGCCTGGGCAACAGAGACCCTGTCTCAACCACCACCACCACCACCACCCCTACTACCCCTGTATTCAAGGT AAAAATTGAAGTTTGTATGATGTAAGAGATGAGAAAAACCCAACAGGAAACACAGACACATCCTCCAGTTCTATCAATGGATTGTGCAGA CACTGAGTTTTTAGAAAAACATATCCACGGTAACCGGTCCCTGGCAATTCTGTTTACATGAAATGGGGAGAAAGTCACCGAAATGGGTGC CGCCGGCCCCCACTCCCAATTCATTCCCTAACCTGCAAACCTTTCCAACTTCTCACGTCAGGCCTTTGAGAATTCTTTCCCCCTCTCCTG GTTTCCACACCTCAGACACGCACAGTTCACCAAGTGCCTTCTGTAGTCACATGAATTGAAAAGGAGACGCTGCTCCCACGGAGGGGAGCA GGAATGCTGCACTGTTTACACCCTGACTGTGCTTGCAGAGAAAGGCAATGCCAGGGTCAAGCAGCTCAAGAGGCAGCTGGAGGAGGCAGA GGAGGAGTCCCAGCGCATCAACGCCAACCGCAGGAAGCTGCAGCGGGAGCTGGATGAGGCCACGGAGAGCAACGAGGCCATGGGCCGCGA GGTGAACGCACTCAAGAGCAAGCTCAGAGAGAAACAGGCGGCCACCAAGTCGCTGAAGCAGAAAGACAAGAAGCTGAAGGAAATCTTGCT GCAGGTGGAGGACGAGCGCAAGATGGCCGAGCAGTACAAGGAGCAGGCCGAGCAGCTCAGCAACGAGCTGGCCACAGAGCGCAGCACGGC CCAGAAGAATGAGAGTGCCCGGCAGCAGCTCGAGCGGCAGAACAAGGAGCTCCGGAGCAAGCTCCACGAGATGGAGGGGGCCGTCAAGTC CAAGTTCAAGTCCACCATCGCGGCGCTGGAGGCCAAGATTGCACAGCTGGAGGAGCAGGTCGAGCAGGAGGCCAGGAACGCACTCCAGGA CGAGAAGCGCCGCCTGGAGGCCCGGATCGCCCAGCTGGAGGAGGAGCTGGAGGAGGAGCAGGGCAACATGGAGGCCATGAGCGACCGGGT CCGCAAAGCCACACAGCAGGACCTCGCCGCCGCTGAGAGGGCTCGCAAACAAGCGGACCTCGAGAAGGAGGAACTGGCAGAGGAGCTGGC CAGTAGCCTGTCGGGAAGGCTCAGATGAAGGACTTTCAAAGAGAGCTGGAAGATGCCCGTGCCTCCAGAGATGAGATCTTTGCCACAGCC AAAGAGAATGAGAAGAAAGCCAAGAGCTTGGAAGCAGACCTCATGCAGCTACAAGAGCTTCACGAGTATGAGACGGAACTGGAAGACGAG CGAAAGCAACGTGCCCTGGCAGCTGCAGCAAAGAAGAAGCTGGAAGGGGACCTGAAAGACCTGGAGCTTCAGGCCGACTCTGCCATCAAG GGGAGGGAGGAAGCCATCAAGCAGCTACGCAAACTGCAGGTCCATGAGCTGGAGAAGTCCAAGCGGGCCCTGGAGACCCAGATGGAGGAG ATGAAGACGCAGCTGGAAGAGCTGGAGGACGAGCTGCAAGCCACGGAGGACGCCAAACTGCGGCTGGAAGTCAACATGCAGGCGCTCAAG GGCCAGTTCGAAAGGGATCTCCAAGCCCGGGACGAGCAGAATGAGGAGAAGAGGAGGCAACTGCAGAGACAGTTGTTAGCCGAGGAGAAA AACATCTCTTCCAAATACGCGGATGAGAGGGACAGAGCTGAGGCAGAAGCCAGGGAGAAGGAAACCAAGGCCCTGTCCCTGGCTCGGGCC CTTGAAGAGGCCTTGGAAGCCAAAGAGGAACTCGAGCGGACCAACAAAATGCTCAAAGCCGAAATGGAAGACCTGGTCAGCTCCAAGGAT >26909_26909_2_EPC2-MYH11_EPC2_chr2_149526741_ENST00000258484_MYH11_chr16_15818065_ENST00000396324_length(amino acids)=446AA_BP= MSKLSFRARALDAAKPLPIYRGKDMPDLNDCVSINRAVPQMPTGMEKEEESEHHLQRAISAQQVFREKKESMVIPVPEAESNVNYYNRLY KGEFKQPKQFIHIQPFNLDNEQPDYDMDSEDETLLNRLNRKMEIKPLQFEIMIDRLEKASSNQLVTLQEAKLLLNEDDYLIKAVYDYWVR KRKNCRGPSLIPQIKQEKRDGSTNNDPYVAFRRRTEKMQTRKNRKNDEASYEKMLKLRREFSRAITILEMIKRREKTKRELLHLTLEVVE KRYHLGDYGGEILNEVKISRSEKELYATPATLHNGNHHKVQECKTKHPHHLSLKEEASDVVRQKKKYPKKPKAEALITSQQPTPETLPVI -------------------------------------------------------------- >26909_26909_3_EPC2-MYH11_EPC2_chr2_149526741_ENST00000258484_MYH11_chr16_15818065_ENST00000452625_length(transcript)=3702nt_BP=1242nt GCCGCCCGGGCTGTTCCTGTAAGGCGGGGAGACAATGAGTAAACTCTCCTTCCGAGCGCGGGCGCTGGACGCCGCCAAGCCGCTGCCTAT CTACCGCGGCAAGGACATGCCTGATCTCAACGACTGCGTCTCCATCAACCGGGCCGTGCCCCAGATGCCCACCGGGATGGAGAAGGAGGA GGAATCGGAACATCATTTACAGCGAGCAATTTCAGCACAGCAAGTGTTTAGAGAAAAAAAAGAGAGTATGGTCATTCCTGTTCCTGAGGC AGAGAGCAACGTCAACTATTACAATCGCTTGTACAAAGGAGAGTTTAAACAGCCAAAACAGTTCATTCATATTCAGCCTTTTAATCTAGA CAACGAGCAACCAGATTATGATATGGATTCAGAAGATGAGACTTTATTAAATAGACTTAACAGAAAGATGGAAATTAAGCCTTTGCAATT TGAAATTATGATTGACAGACTTGAAAAAGCCAGTTCTAATCAGCTTGTAACACTTCAAGAAGCAAAACTGCTGCTAAACGAAGATGATTA CCTTATTAAAGCTGTATATGACTACTGGGTGAGAAAACGTAAAAACTGCAGGGGGCCATCCCTCATTCCTCAGATAAAACAAGAGAAAAG AGATGGCTCTACCAACAATGACCCTTATGTTGCCTTTCGGAGAAGAACAGAGAAAATGCAAACTCGAAAGAATCGTAAGAATGATGAAGC CTCTTATGAAAAGATGTTGAAACTGAGACGAGAATTTAGTAGAGCCATAACAATTTTGGAAATGATTAAGAGAAGAGAGAAAACAAAACG AGAATTATTGCACTTAACCTTAGAAGTTGTGGAGAAAAGATACCATTTGGGAGACTATGGTGGTGAAATCCTTAATGAAGTAAAAATCAG TAGATCAGAAAAAGAGTTATATGCCACTCCAGCAACTCTTCATAATGGAAATCATCACAAAGTTCAAGAATGTAAAACTAAGCACCCTCA TCATTTGTCTTTGAAAGAAGAGGCTTCTGATGTGGTTCGTCAAAAGAAGAAGTACCCAAAGAAGCCTAAAGCAGAGGCTTTGATAACATC TCAGCAACCCACTCCTGAGACATTGCCTGTGATCAATAAGAGTGACATTAAGCAATATGATTTTCACAGCTCAGATGAAGATGAATTTCC ACAGCGGAAGAAGAAAATGATCCTGATGGTCCCTGTGCTTTCAGAAGGCGGGCAGGATGCCAGTATTATGCTGCGAGGAAACGAGACCTC TTTCGTTCCTTCTAGAAGGTCTGGAGGACGTAGAGTTATTGAAAATGCAGATGGTTCTGAGGAGGAAACGGACACTCGAGACGCAGACTT CAATGGAACCAAGGCCAGTGAATAAGCAACTTTCTACAGTTTTGCACCACGGCAAGAAAACCAAAAACCAAAACAAACAAACAAAAAAAA CCCAACAACAACCCAGAACAAAGCAAAACCCAGCAGACTGTACTTAGCATTGTCTAAATCCATTCTCAAATTCCAAATATCACAGACACC CCTCACACAAGGAATATAAAAACCACCACCCTCCAGCCTGGGCAACGTAGTAAAACCTCATCTATACAAGAATTTAAAAATAAGCTGGGC GTGGTGGTACACACCTGTGGTCCCAGCTACTAGGGAGGCTGAGCCAGGAAGAACGCTCCAGCCCAGGACTTCGAGGCTGCAATGAGCTAT AATTGCATCATTGCACTCCAGCCTGGGCAACAGAGACCCTGTCTCAACCACCACCACCACCACCACCCCTACTACCCCTGTATTCAAGGT AAAAATTGAAGTTTGTATGATGTAAGAGATGAGAAAAACCCAACAGGAAACACAGACACATCCTCCAGTTCTATCAATGGATTGTGCAGA CACTGAGTTTTTAGAAAAACATATCCACGGTAACCGGTCCCTGGCAATTCTGTTTACATGAAATGGGGAGAAAGTCACCGAAATGGGTGC CGCCGGCCCCCACTCCCAATTCATTCCCTAACCTGCAAACCTTTCCAACTTCTCACGTCAGGCCTTTGAGAATTCTTTCCCCCTCTCCTG GTTTCCACACCTCAGACACGCACAGTTCACCAAGTGCCTTCTGTAGTCACATGAATTGAAAAGGAGACGCTGCTCCCACGGAGGGGAGCA GGAATGCTGCACTGTTTACACCCTGACTGTGCTTAGGGCCCCCCCCACAGGAAACTTCGCAGTGATGCACCAGGCAGAGAAAGGCAATGC CAGGGTCAAGCAGCTCAAGAGGCAGCTGGAGGAGGCAGAGGAGGAGTCCCAGCGCATCAACGCCAACCGCAGGAAGCTGCAGCGGGAGCT GGATGAGGCCACGGAGAGCAACGAGGCCATGGGCCGCGAGGTGAACGCACTCAAGAGCAAGCTCAGAGAGAAACAGGCGGCCACCAAGTC GCTGAAGCAGAAAGACAAGAAGCTGAAGGAAATCTTGCTGCAGGTGGAGGACGAGCGCAAGATGGCCGAGCAGTACAAGGAGCAGGCCGA GCAGCTCAGCAACGAGCTGGCCACAGAGCGCAGCACGGCCCAGAAGAATGAGAGTGCCCGGCAGCAGCTCGAGCGGCAGAACAAGGAGCT CCGGAGCAAGCTCCACGAGATGGAGGGGGCCGTCAAGTCCAAGTTCAAGTCCACCATCGCGGCGCTGGAGGCCAAGATTGCACAGCTGGA GGAGCAGGTCGAGCAGGAGGCCAGGAACGCACTCCAGGACGAGAAGCGCCGCCTGGAGGCCCGGATCGCCCAGCTGGAGGAGGAGCTGGA GGAGGAGCAGGGCAACATGGAGGCCATGAGCGACCGGGTCCGCAAAGCCACACAGCAGGACCTCGCCGCCGCTGAGAGGGCTCGCAAACA AGCGGACCTCGAGAAGGAGGAACTGGCAGAGGAGCTGGCCAGTAGCCTGTCGGGAAGGCTCAGATGAAGGACTTTCAAAGAGAGCTGGAA GATGCCCGTGCCTCCAGAGATGAGATCTTTGCCACAGCCAAAGAGAATGAGAAGAAAGCCAAGAGCTTGGAAGCAGACCTCATGCAGCTA CAAGAGCTTCACGAGTATGAGACGGAACTGGAAGACGAGCGAAAGCAACGTGCCCTGGCAGCTGCAGCAAAGAAGAAGCTGGAAGGGGAC CTGAAAGACCTGGAGCTTCAGGCCGACTCTGCCATCAAGGGGAGGGAGGAAGCCATCAAGCAGCTACGCAAACTGCAGGTCCATGAGCTG GAGAAGTCCAAGCGGGCCCTGGAGACCCAGATGGAGGAGATGAAGACGCAGCTGGAAGAGCTGGAGGACGAGCTGCAAGCCACGGAGGAC GCCAAACTGCGGCTGGAAGTCAACATGCAGGCGCTCAAGGGCCAGTTCGAAAGGGATCTCCAAGCCCGGGACGAGCAGAATGAGGAGAAG AGGAGGCAACTGCAGAGACAGTTGTTAGCCGAGGAGAAAAACATCTCTTCCAAATACGCGGATGAGAGGGACAGAGCTGAGGCAGAAGCC AGGGAGAAGGAAACCAAGGCCCTGTCCCTGGCTCGGGCCCTTGAAGAGGCCTTGGAAGCCAAAGAGGAACTCGAGCGGACCAACAAAATG CTCAAAGCCGAAATGGAAGACCTGGTCAGCTCCAAGGATGACGTGGGCAAGAACCGGCAACTCGTGTCCAACCTGGAAAAGAAGCAGAGG >26909_26909_3_EPC2-MYH11_EPC2_chr2_149526741_ENST00000258484_MYH11_chr16_15818065_ENST00000452625_length(amino acids)=446AA_BP= MSKLSFRARALDAAKPLPIYRGKDMPDLNDCVSINRAVPQMPTGMEKEEESEHHLQRAISAQQVFREKKESMVIPVPEAESNVNYYNRLY KGEFKQPKQFIHIQPFNLDNEQPDYDMDSEDETLLNRLNRKMEIKPLQFEIMIDRLEKASSNQLVTLQEAKLLLNEDDYLIKAVYDYWVR KRKNCRGPSLIPQIKQEKRDGSTNNDPYVAFRRRTEKMQTRKNRKNDEASYEKMLKLRREFSRAITILEMIKRREKTKRELLHLTLEVVE KRYHLGDYGGEILNEVKISRSEKELYATPATLHNGNHHKVQECKTKHPHHLSLKEEASDVVRQKKKYPKKPKAEALITSQQPTPETLPVI -------------------------------------------------------------- >26909_26909_4_EPC2-MYH11_EPC2_chr2_149526741_ENST00000258484_MYH11_chr16_15818065_ENST00000576790_length(transcript)=3087nt_BP=1242nt GCCGCCCGGGCTGTTCCTGTAAGGCGGGGAGACAATGAGTAAACTCTCCTTCCGAGCGCGGGCGCTGGACGCCGCCAAGCCGCTGCCTAT CTACCGCGGCAAGGACATGCCTGATCTCAACGACTGCGTCTCCATCAACCGGGCCGTGCCCCAGATGCCCACCGGGATGGAGAAGGAGGA GGAATCGGAACATCATTTACAGCGAGCAATTTCAGCACAGCAAGTGTTTAGAGAAAAAAAAGAGAGTATGGTCATTCCTGTTCCTGAGGC AGAGAGCAACGTCAACTATTACAATCGCTTGTACAAAGGAGAGTTTAAACAGCCAAAACAGTTCATTCATATTCAGCCTTTTAATCTAGA CAACGAGCAACCAGATTATGATATGGATTCAGAAGATGAGACTTTATTAAATAGACTTAACAGAAAGATGGAAATTAAGCCTTTGCAATT TGAAATTATGATTGACAGACTTGAAAAAGCCAGTTCTAATCAGCTTGTAACACTTCAAGAAGCAAAACTGCTGCTAAACGAAGATGATTA CCTTATTAAAGCTGTATATGACTACTGGGTGAGAAAACGTAAAAACTGCAGGGGGCCATCCCTCATTCCTCAGATAAAACAAGAGAAAAG AGATGGCTCTACCAACAATGACCCTTATGTTGCCTTTCGGAGAAGAACAGAGAAAATGCAAACTCGAAAGAATCGTAAGAATGATGAAGC CTCTTATGAAAAGATGTTGAAACTGAGACGAGAATTTAGTAGAGCCATAACAATTTTGGAAATGATTAAGAGAAGAGAGAAAACAAAACG AGAATTATTGCACTTAACCTTAGAAGTTGTGGAGAAAAGATACCATTTGGGAGACTATGGTGGTGAAATCCTTAATGAAGTAAAAATCAG TAGATCAGAAAAAGAGTTATATGCCACTCCAGCAACTCTTCATAATGGAAATCATCACAAAGTTCAAGAATGTAAAACTAAGCACCCTCA TCATTTGTCTTTGAAAGAAGAGGCTTCTGATGTGGTTCGTCAAAAGAAGAAGTACCCAAAGAAGCCTAAAGCAGAGGCTTTGATAACATC TCAGCAACCCACTCCTGAGACATTGCCTGTGATCAATAAGAGTGACATTAAGCAATATGATTTTCACAGCTCAGATGAAGATGAATTTCC ACAGCGGAAGAAGAAAATGATCCTGATGGTCCCTGTGCTTTCAGAAGGCGGGCAGGATGCCAGTATTATGCTGCGAGGAAACGAGACCTC TTTCGTTCCTTCTAGAAGGTCTGGAGGACGTAGAGTTATTGAAAATGCAGATGGTTCTGAGGAGGAAACGGACACTCGAGACGCAGACTT CAATGGAACCAAGGCCAGTGAATAAGCAACTTTCTACAGTTTTGCACCACGGCAAGAAAACCAAAAACCAAAACAAACAAACAAAAAAAA CCCAACAACAACCCAGAACAAAGCAAAACCCAGCAGACTGTACTTAGCATTGTCTAAATCCATTCTCAAATTCCAAATATCACAGACACC CCTCACACAAGGAATATAAAAACCACCACCCTCCAGCCTGGGCAACGTAAGGGCCCCCCCCACAGGAAACTTCGCAGTGATGCACCAGGC AGAGAAAGGCAATGCCAGGGTCAAGCAGCTCAAGAGGCAGCTGGAGGAGGCAGAGGAGGAGTCCCAGCGCATCAACGCCAACCGCAGGAA GCTGCAGCGGGAGCTGGATGAGGCCACGGAGAGCAACGAGGCCATGGGCCGCGAGGTGAACGCACTCAAGAGCAAGCTCAGAGAGAAACA GGCGGCCACCAAGTCGCTGAAGCAGAAAGACAAGAAGCTGAAGGAAATCTTGCTGCAGGTGGAGGACGAGCGCAAGATGGCCGAGCAGTA CAAGGAGCAGGCCGAGCAGCTCAGCAACGAGCTGGCCACAGAGCGCAGCACGGCCCAGAAGAATGAGAGTGCCCGGCAGCAGCTCGAGCG GCAGAACAAGGAGCTCCGGAGCAAGCTCCACGAGATGGAGGGGGCCGTCAAGTCCAAGTTCAAGTCCACCATCGCGGCGCTGGAGGCCAA GATTGCACAGCTGGAGGAGCAGGTCGAGCAGGAGGCCAGGAACGCACTCCAGGACGAGAAGCGCCGCCTGGAGGCCCGGATCGCCCAGCT GGAGGAGGAGCTGGAGGAGGAGCAGGGCAACATGGAGGCCATGAGCGACCGGGTCCGCAAAGCCACACAGCAGGACCTCGCCGCCGCTGA GAGGGCTCGCAAACAAGCGGACCTCGAGAAGGAGGAACTGGCAGAGGAGCTGGCCAGTAGCCTGTCGGGAAGGCTCAGATGAAGGACTTT CAAAGAGAGCTGGAAGATGCCCGTGCCTCCAGAGATGAGATCTTTGCCACAGCCAAAGAGAATGAGAAGAAAGCCAAGAGCTTGGAAGCA GACCTCATGCAGCTACAAGAGCTTCACGAGTATGAGACGGAACTGGAAGACGAGCGAAAGCAACGTGCCCTGGCAGCTGCAGCAAAGAAG AAGCTGGAAGGGGACCTGAAAGACCTGGAGCTTCAGGCCGACTCTGCCATCAAGGGGAGGGAGGAAGCCATCAAGCAGCTACGCAAACTG CAGGTCCATGAGCTGGAGAAGTCCAAGCGGGCCCTGGAGACCCAGATGGAGGAGATGAAGACGCAGCTGGAAGAGCTGGAGGACGAGCTG CAAGCCACGGAGGACGCCAAACTGCGGCTGGAAGTCAACATGCAGGCGCTCAAGGGCCAGTTCGAAAGGGATCTCCAAGCCCGGGACGAG CAGAATGAGGAGAAGAGGAGGCAACTGCAGAGACAGTTGTTAGCCGAGGAGAAAAACATCTCTTCCAAATACGCGGATGAGAGGGACAGA GCTGAGGCAGAAGCCAGGGAGAAGGAAACCAAGGCCCTGTCCCTGGCTCGGGCCCTTGAAGAGGCCTTGGAAGCCAAAGAGGAACTCGAG CGGACCAACAAAATGCTCAAAGCCGAAATGGAAGACCTGGTCAGCTCCAAGGATGACGTGGGCAAGAACCGGCAACTCGTGTCCAACCTG >26909_26909_4_EPC2-MYH11_EPC2_chr2_149526741_ENST00000258484_MYH11_chr16_15818065_ENST00000576790_length(amino acids)=446AA_BP= MSKLSFRARALDAAKPLPIYRGKDMPDLNDCVSINRAVPQMPTGMEKEEESEHHLQRAISAQQVFREKKESMVIPVPEAESNVNYYNRLY KGEFKQPKQFIHIQPFNLDNEQPDYDMDSEDETLLNRLNRKMEIKPLQFEIMIDRLEKASSNQLVTLQEAKLLLNEDDYLIKAVYDYWVR KRKNCRGPSLIPQIKQEKRDGSTNNDPYVAFRRRTEKMQTRKNRKNDEASYEKMLKLRREFSRAITILEMIKRREKTKRELLHLTLEVVE KRYHLGDYGGEILNEVKISRSEKELYATPATLHNGNHHKVQECKTKHPHHLSLKEEASDVVRQKKKYPKKPKAEALITSQQPTPETLPVI -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EPC2-MYH11 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EPC2-MYH11 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EPC2-MYH11 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | EPC2 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Tgene | C4707243 | Familial thoracic aortic aneurysm and aortic dissection | 10 | CLINGEN;GENOMICS_ENGLAND | |
Tgene | C0023467 | Leukemia, Myelocytic, Acute | 2 | CTD_human | |
Tgene | C0023479 | Acute myelomonocytic leukemia | 2 | CTD_human;ORPHANET | |
Tgene | C0026998 | Acute Myeloid Leukemia, M1 | 2 | CTD_human | |
Tgene | C1851504 | Aortic aneurysm, familial thoracic 4 | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C1879321 | Acute Myeloid Leukemia (AML-M2) | 2 | CTD_human | |
Tgene | C1608393 | Megacystis microcolon intestinal hypoperistalsis syndrome | 1 | GENOMICS_ENGLAND;ORPHANET |